Myelodysplastic Syndromes, Version 2.2015: Featured Updates to the NCCN Guidelines

The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a highly variable disease course that depends largely on risk factors. Risk evaluation is therefore a critical component of decision-making in the treatment of MDS. The development of new...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Natl Compr Canc Netw
Huvudupphovsmän: Greenberg, Peter L., Stone, Richard M., Bejar, Rafael, Bennett, John M., Bloomfield, Clara D., Borate, Uma, De Castro, Carlos M., Deeg, H. Joachim, DeZern, Amy E., Fathi, Amir T., Frankfurt, Olga, Gaensler, Karin, Garcia-Manero, Guillermo, Griffiths, Elizabeth A., Head, David, Klimek, Virginia, Komrokji, Rami, Kujawski, Lisa A., Maness, Lori J., O’Donnell, Margaret R., Pollyea, Daniel A., Scott, Bart, Shami, Paul J., Stein, Brady L., Westervelt, Peter, Wheeler, Benton, Shead, Dorothy A., Smith, Courtney
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696005/
https://ncbi.nlm.nih.gov/pubmed/25736003
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk